Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. [electronic resource]
Producer: 20081114Description: 1626-36 p. digitalISSN:- 1524-4539
- Administration, Oral
- Aged
- Clopidogrel
- Coronary Thrombosis -- complications
- Diabetes Mellitus, Type 1 -- complications
- Diabetes Mellitus, Type 2 -- complications
- Female
- Humans
- Hypoglycemic Agents -- administration & dosage
- Insulin -- administration & dosage
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Myocardial Infarction -- complications
- Myocardial Ischemia -- complications
- Piperazines -- administration & dosage
- Platelet Aggregation Inhibitors -- administration & dosage
- Prasugrel Hydrochloride
- Thiophenes -- administration & dosage
- Thrombolytic Therapy -- methods
- Ticlopidine -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.